In its Phase III CB-5945 ascent study for the treatment of OIC Pipeline Drugs Market, Cubist Pharmaceuticals has begun enrolling patients. One of four registrational studies on patients with chronic non-cancer pain is the multicentre, long-term safety study. The placebo-controlled, double-blind, randomised (1:1) study will enroll 1,400 eligible US and Canadian patients to evaluate CB-5945 (0.25...

The Internet of Things is thought to be behind in 2021. Giacomo Lee explains that IoT cyber security issues that plagued the technology in the 2010s persist today. One of the many technology themes that have been impacted by the pandemic and the ongoing shortage of chips is the Internet of Things (IoT), which is seen as a year of cyber security catch-up as the world reopens for business. The...

A brand-new morphine derivative called Morphine-6-Glucuronide (M6G) is being developed by the biopharmaceutical company PAION. A UK company called Developm CeNeS specialized in the creation of drugs that affect the central nervous system (CNS). The company's lead compound, M6G, is indicated for the management of moderate to severe pain following surgery. The M6G investigational new drug...

Boehringer Ingelheim's innovative non-catalytic site integrase inhibitors (NCINIs) for HIV have been granted exclusive worldwide rights to Gilead Sciences. The lead compound BI 224436 from Boehringer Ingelheim, which was recently tested in a Phase 1a dose-escalation study, is included in the agreement. NCINIs inhibit HIV 1 Integrase Drugs Development market by binding to a novel site and...

The report includes Cells Expressing CD44 Antigen (CDw44, Epican, GP90, Lymphocyte Homing/Adhesion Receptor, HUTCH I, Hermes Antigen, Hyaluronate Receptor, Phagocytic Glycoprotein 1, or CD44) Drugs in Development by Therapy Areas and Indications, Stages, MoA, Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration ( The report also discusses the...

The 78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type, and Key Players report provides a comprehensive analysis of the targeted pipeline therapeutics that are Analysis by...

Nightmare disorder affects many people with post-traumatic stress disorder. These disruptive, weekly nightmares cause them to relive their trauma and disrupt their sleep. NightWare has now developed a platform for stopping these nightmares without waking the wearer by utilizing the Apple smart watch. Chloe Kent talks to NightWare CEO Grady Hannah about the company's approach to battling...

Grifols' Procelix Panther System with Automation Ready Technology (ART) has been approved by the US Food and Drug Administration (FDA).On a single, integrated platform, this system automates every aspect of NAT-based blood screening. It is said to have the highest throughput of results per square meter. Tests for various viruses, including HIV, hepatitis A, B, C, and E, West Nile virus, and...

In 2022, the market for clinical chemistry analyzers will be worth $2.40 billion. Analytes like cholesterol, electrolytes, glucose, and others are measured in blood, serum, plasma, or urine samples using clinical chemistry analyzers. Semi-automated clinical chemistry analyzers, automated clinical chemistry analyzers, and integrated clinical chemistry analyzers are all included in this...

According to Public Health England, the diagnosed prevalence of dementia in the 65-and-over population was 4.3% in 2018 and is expected to rise in the future. Dementia Pipeline Drugs Market is a neurodegenerative brain disease that cannot be reversed. It is characterized by the death of brain cells, which causes a gradual decline in memory and cognitive abilities like language, thinking, and...